SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE_02_017000202 | chr12:76416236-76424189![]() |
Sample_02_0170 | Prostate | LNCaP_R1881_DOX | 202 | 2 | 192 | 9 | 0 | 32 | 70 | OSBPL8,BBS10 |
SE_02_016900327 | chr12:76416244-76424149![]() |
Sample_02_0169 | Prostate | LNCaP_R1881 | 327 | 2 | 192 | 9 | 0 | 32 | 70 | OSBPL8,BBS10 |
SE_02_067300471 | chr12:76416578-76424330![]() |
Sample_02_0673 | Prostate | LNCAP_FA | 471 | 3 | 189 | 9 | 0 | 32 | 70 | OSBPL8,BBS10 |
SE_02_077400334 | chr12:76418792-76424276![]() |
Sample_02_0774 | Prostate | 22Rv1_delSite1_Clone11/12-D8 | 334 | 3 | 130 | 7 | 0 | 32 | 70 | OSBPL8,BBS10 |
SE_01_006800173 | chr12:76419072-76443979![]() |
Sample_01_0068 | Prostate: derived from metastatic site: vertebral metastasis | VCaP | 173 | 4 | 602 | 43 | 3 | 42 | 70 | OSBPL8,BBS10 |
SE_02_010400829 | chr12:76515017-76560714![]() |
Sample_02_0104 | Blood | neutrophils | 829 | 8 | 1088 | 88 | 3 | 69 | 287 | OSBPL8 |
SE_02_057900333 | chr12:76516507-76570509![]() |
Sample_02_0579 | Blood | HEL_sgNeg2 | 333 | 27 | 1276 | 100 | 4 | 98 | 287 | OSBPL8 |
SE_02_057600320 | chr12:76518825-76570572![]() |
Sample_02_0576 | Blood | HEL_sgLKB1e2 | 320 | 18 | 1222 | 93 | 3 | 98 | 287 | OSBPL8 |
SE_02_058000330 | chr12:76518981-76570523![]() |
Sample_02_0580 | Blood | HEL_sgSIK3e4 | 330 | 17 | 1217 | 93 | 3 | 98 | 287 | OSBPL8 |
SE_02_149200574 | chr12:76527572-76570453![]() |
Sample_02_1492 | Peripheral blood | CD34+ derived peripheral blood-derived mast cells | 574 | 16 | 1012 | 74 | 3 | 98 | 287 | OSBPL8 |
SE_02_033600452 | chr12:76528419-76563194![]() |
Sample_02_0336 | Haematopoietic and lymphoid tissue | SET2 | 452 | 5 | 814 | 62 | 2 | 75 | 287 | OSBPL8 |
SE_02_087500683 | chr12:76528477-76570585![]() |
Sample_02_0875 | Peripheral blood | Peripheral blood-derived mast cells | 683 | 17 | 992 | 75 | 3 | 98 | 287 | OSBPL8,ZDHHC17 |
SE_02_117000060 | chr12:76530652-76569801![]() |
Sample_02_1170 | Blood | HEL92.1.7 | 60 | 14 | 915 | 68 | 3 | 98 | 287 | OSBPL8 |
SE_02_148501059 | chr12:76533927-76563073![]() |
Sample_02_1485 | Bone | SK-ES-1 | 1059 | 6 | 682 | 53 | 2 | 75 | 287 | OSBPL8 |
SE_02_006400722 | chr12:76545522-76561054![]() |
Sample_02_0064 | Embryo | DN-Early_G1 | 722 | 2 | 382 | 32 | 1 | 55 | 204 | OSBPL8 |
SE_02_075001013 | chr12:76554176-76560654![]() |
Sample_02_0750 | Lymphoma | Rec-1_GSI | 1013 | 7 | 136 | 13 | 1 | 34 | 204 | OSBPL8 |
SE_02_061701137 | chr12:76554356-76570626![]() |
Sample_02_0617 | HSPC | FL CD34+CD38-/lowCD90+ HSPC | 1137 | 3 | 369 | 29 | 2 | 63 | 204 | OSBPL8 |
SE_02_059300341 | chr12:76554407-76570327![]() |
Sample_02_0593 | Fetal spleenocytes | fetal naive T cells | 341 | 4 | 358 | 28 | 2 | 63 | 204 | OSBPL8 |
SE_02_146001474 | chr12:76557292-76570480![]() |
Sample_02_1460 | Blood | Mutz-3 | 1474 | 2 | 303 | 25 | 2 | 60 | 204 | OSBPL8 |